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Endogenous Endotoxemia During Orthotopic Liver Transplantation in Dogs 
T. Miyata, S. Todo, O. Imventarza, Y. Ueda, H. Furukawa, and T.E. Starzl 
AL THOUGH the I-year survival rate after clinical 
orthotopic liver transplantation (OL TX) has been 
improved to about 70%,' 15% of the patients still die within 
the first month as a result of complications. such as shock, 
multiple organ failure, and bleeding. Although various fac-
tors have been found to be involved in these postoperative 
complications, the overall mechanism has not been well 
elucidated. 
The liver normally contributes more than 80% of the blood 
cleaning functions of the reticuloendothelial system.2 During 
OL TX, this hepatic contribution temporarily is lost (anhe-
patic phase), and toxic substances including endotoxin can 
flood the circulation. To our knowledge, there has been no 
report concerning endotoxemia during OL TX. 
Endotoxin is a cell wall component of gram-negative 
bacteria and has lipid A as the central component in its 
structure. Endotoxin triggers shock,3 pulmonary failure,4 and 
disseminated intravascular coagulation. 5 It is absorbed from 
the intestine even under conditions of health. 6 Recently, a 
highly sensitive quantitative method has been developed for 
plasma endotoxin determination using chromogenic sub-
strate and perchloric acid. 7 
MATERIALS AND METHODS 
We used a modification of this method' to determine whether 
endoLOxemia occurred at the time of OLTX in dogs. Briefly, dogs' 
platelet poor plasma was added to perchloric acid, and the neutral-
ized supernatant from this mixture was incubated with Japanese 
horseshoe crab Tachyplcustridentatus and a chromogenic substrate 
(Seikagaku Kogyo, Tokyo). The absorbance was measured at 545 
nm after diazotization. All procedures before diazotization were 
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Fig 1. Change of peripheral blood endotoxin levels in dogs 
not given neomycin preoperatively (group A). 
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Fig 2. Change of peripheral blood endotoxin levels in neomy-
cin-treated dogs (group B). 
carried out in a pyrogen-free manner. As a reference, endotoxin 0111 
B4 was used. Student's t-test was used for the comparison of 
endotoxin values, and the X' test was employed for the comparison of 
mortality. 
Sixteen healthy beagle female recipients weighing 10-15 kg 
underwent OLTX from mongrel donors of either sex. The experi-
ments were divided into two groups. In group A (n = 9). no 
antibiotic treatment was given before the OL TX, whereas in group B 
(n = 7), 750 mg neomycin was given by mouth 3 times/day for 3 
days, All the operations were performed by the same team, using a 
standard technique! The livers were infused and preserved with 
chilled lactated Ringer's solution and had cold ischemia times of 
25-40 minutes before portal revascularization. Beginning on the 
morning after transplantation, the dogs were treated orally with 20 
mg/kg/day CyA. which was dissolved in ethanol and in olive oil to a 
concentration of 100 mg/ml of solution. 
Samples for endotoxin measurement were drawn from a periph-
eral vein, collecting 3 ml in a pyrogen-free disposable syringe. The 
blood was anticoagulated with 10 units heparin/ml sample. Sam-
pling was immediately before liver grafting, at the end of the 
anhepatic phase, 3, 12. and 24 hours after the end of the anhepatic 
phase, and 3 and 7 days after the operation if the dog lived this long. 
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The sample was immediately centrifuged at 3000 rpm for 10 minutes 
and stored at - 80°C until the analysis. 
RESULTS 
Before OL TX, the endotoxin levels in the peripheral blood 
«5 pg/ ml) did not differ between group A and group B. 
During the anhepatic phase, the maximum endotoxin levels 
in group A increased to 128.1 ± 20.6 pg/ml (Fig 1) and in 
group B to 59.0 ± 15.5 pg/ml (Fig 2). The difference 
between groups was significant (p < 0.01). This endotox-
emia lasted for more than 12 hours after the end of the 
anhepatic phase. Seven of the 9 dogs not given neomycin 
(group A) died within 14 days of pulmonary failure (5), 
bleeding (4), and lymphatic ascites (1); 3 of these animals 
had more than one principal cause of death. The periopera-
tive endotoxemia tended to be greater in the animals that did 
not survive through the 2-week observation period (Figs I, 
2). Two of the 7 dogs given neomycin (group B) died within 
14 days, both from intestinal intussusception. The difference 
between the groups in 2-week mortality was significant 
(p < 0.05). 
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CONCLUSIONS 
These data suggest that endogenous endotoxemia occurring 
during OL TX may play an important role in the develop-
ment of complications after OL TX. Endotoxin currently is 
being measured during and after OLTX in humans. 
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